BlackRock Advisors’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-227,163
Closed -$8.13M 3722
2014
Q4
$8.13M Sell
227,163
-29,571
-12% -$883K 0.01% 837
2014
Q3
$6.67M Buy
256,734
+35,349
+16% +$1.02M 0.01% 896
2014
Q2
$7.32M Buy
221,385
+101,007
+84% +$2.92M 0.01% 870
2014
Q1
$3.6M Buy
120,378
+56,424
+88% +$1.94M ﹤0.01% 1039
2013
Q4
$1.94M Buy
63,954
+4,558
+8% +$126K ﹤0.01% 1197
2013
Q3
$1.89M Buy
59,396
+321
+0.5% +$7.37K ﹤0.01% 1174
2013
Q2
$893K Buy
+59,075
New +$818K ﹤0.01% 1430

Other funds holding NPSP

BlackRock Advisors's NPSP Position: Q1 2015 in Review

BlackRock Advisors sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 227,163 shares — an estimated $8.13M sold.

BlackRock Advisors first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $8.13M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • BlackRock Advisors reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BlackRock Advisors sold 227,163 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $8.13M.
  • BlackRock Advisors first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BlackRock Advisors's NPS PHARMACEUTICALS INC position peaked at $8.13M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.